Apotex Inc. Email Format

Pharmaceutical ManufacturingOntario, Canada5001-10000 Employees

Apotex Inc. is a global pharmaceutical manufacturing company headquartered in Toronto, Canada, with an address at 150 Signet Drive, North York, Ontario M9L 1T9, and a workforce of about 5,001 to 10,000 employees. Its portfolio comprises more than 550 generic, biosimilar, and innovative medicines, along with more than 225 natural health products, reflecting a focus on improving access to affordable health care worldwide. Based in Canada, Apotex is the largest Canadian-based pharmaceutical company and is described as a health partner of choice in the Americas for licensing and product acquisitions. In June 2026 the company completed an initial public offering and went public; reports indicated the offering raised about $1.3 billion, described as the largest life sciences IPO in TSX history by total proceeds. During 2026 Apotex launched Apo-Semaglutide Injection, a generic equivalent of Ozempic, illustrating continued product development and market entry activity.

Sign up for free to view info

Company overview Employee directory